Benefits of Outsourcing Strategy and IT Technology in Clinical Trials

A review written by Stamenovic M and Dobraca A in Acta Informatica Medica, 25 September 2017.

Aim of this paper is to describe some of models of outsourcing (numerous and response to different types of risks and increment of quality is based on individual problem and situation). Defining whether to outsource or not and whether to build or buy new information technology (IT) is question for contract research organization (CRO) and Pharma companies dealing with clinical trials, so the aim of this paper is to show business model that could make process of decision making less time consuming, less segmented and more efficient.

Read More